Titre:
  • Safety and efficacy of everolimus with exemestane vs. Exemestane alone in elderly patients with HER2-negative, hormone receptor-positive breast cancer in BOLERO-2
Auteur:Pritchard, Kathleen; Burris, Howard H.A.; Ito, Yoshinori; Rugo, Hope; Dakhil, Shaker; Hortobagyi, Gabriel N.; Campone, Mario; Csöszi, Tibor; Baselga, José; Puttawibul, Puttisak; Piccart-Gebhart, Martine; Heng, Daniel Y C; Noguchi, Shinzaburo; Srimuninnimit, Vichien; Bourgeois, Hugues; Gonzalez Martin, Antonio; Osborne, Karen; Panneerselvam, Ashok; Taran, Tetiana; Sahmoud, Tarek; Gnant, Michael
Informations sur la publication:Clinical breast cancer, 13, 6, page (421-432)
Statut de publication:Publié, 2013
Sujet CREF:Cancérologie
Mots-clés:Advanced breast cancer
Endocrine resistance
Geriatric
Progression-free survival
Safety
MeSH keywords:Aged
Aged, 80 and over
Androstadienes -- administration & dosage
Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
Breast Neoplasms -- drug therapy -- metabolism -- mortality -- pathology
Female
Follow-Up Studies
Humans
International Agencies
Neoplasm Metastasis
Neoplasm Recurrence, Local -- drug therapy -- pathology
Neoplasm Staging
Prognosis
Receptor, ErbB-2 -- metabolism
Receptors, Estrogen -- metabolism
Receptors, Progesterone -- metabolism
Safety
Sirolimus -- administration & dosage -- analogs & derivatives
Survival Rate
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:1526-8209
info:doi/10.1016/j.clbc.2013.08.011
info:pii/S1526820913001857
info:scp/84889008307
info:pmid/24267730